<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-04-25T01:38:15Z</responseDate>
  <request identifier="oai:pub.unibl.org:38777" metadataPrefix="oai_dcterms" verb="GetRecord">https://www.pub.unibl.org/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pub.unibl.org:38777</identifier>
        <datestamp>2025-12-10T04:43:23Z</datestamp>
      </header>
      <metadata>
        <oai_dcterms:dcterms xmlns:oai_dcterms="http://www.openarchives.org/OAI/2.0/oai_dcterms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dcterms/ http://www.openarchives.org/OAI/2.0/oai_dcterms.xsd">
          <dcterms:title>Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study</dcterms:title>
          <dcterms:creator xsi:type="dcterms:URI" title="Антонија Верхаз">https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Zdravka Kezić">/unibl/author/Zdravka Kezić</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Ranko Škrbić">/unibl/author/Ranko Škrbić</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Miloš Stoiljković">/unibl/author/Miloš Stoiljković</dcterms:creator>
          <dcterms:date>2019-02</dcterms:date>
          <dcterms:type>Academic Article</dcterms:type>
          <dcterms:type>text</dcterms:type>
          <dcterms:format>81</dcterms:format>
          <dcterms:format>77</dcterms:format>
          <dcterms:identifier>/unibl/sci/idNaucniRad:24182</dcterms:identifier>
          <dcterms:identifier>616.36-002(497.6RS)</dcterms:identifier>
          <dcterms:identifier xsi:type="dcterms:URI" title="info:doi/10.5937/scriptamed50-22255">https://dx.doi.org/10.5937/scriptamed50-22255</dcterms:identifier>
          <dcterms:relation xsi:type="dcterms:URI" title="Медицински факултет">https://med.unibl.org</dcterms:relation>
          <dcterms:relation>STED Journal</dcterms:relation>
          <dcterms:relation>2637-2150</dcterms:relation>
          <dcterms:isPartOf>STED Journal</dcterms:isPartOf>
          <dcterms:isPartOf>2637-2150</dcterms:isPartOf>
          <dcterms:bibliographicCitation>A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, STED Journal, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019</dcterms:bibliographicCitation>
          <dcterms:identifier xsi:type="dcterms:URI">https://www.pub.unibl.org/s/cir/item/38777</dcterms:identifier>
        </oai_dcterms:dcterms>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>